iwyqaxewun.wordpress.com
More than half of the venture capitalistd surveyed in the 2009 Global Venture Capitall Survey conducted by and the said they wouled invest in fewer companies in thenear future, whilw 13 percent of the more than 700 worldwidd respondents said they would increase the number of companie s in which they plan to invest. Despite sluggisgh investment, the annual survey capturede substantial optimism among theinherently risk-taking investors.
“Whil e the recession has slowed the pace of venture investinfg in theshort term, it may very well have expeditecd the global evolution of the industry in the long run,” said Mark Jensen, Deloitte LLP’sw national managing partner of venturr capital services. “In recent years, many entrepreneur s who have been educated in the United Statea have returned home to start companies in theirrhome countries. The playing fielsd continues to level out in termd of new innovationhot spots, broader accesd to capital and growing regional ecosystems that foster risk taking and capitalo formation.
” And venture capitalists agree that investmentsx are more likely to increase in countries outside of the U.S. than domesticallyt in the nextthree years. Half of the venture capitalists surveyeed said investment will increase inAsia (excludingg India); 43 percent named India; 36 percent selecte South America; 25 percent said Europd and the United Kingdom; and just 17 percent said investment woulx increase in North America. Fifty-two percent of all venturew capitalists surveyed said they already invest outsidew theirhome countries.
“As the survey result s suggest, we will see more globalizatioh in thenext decade, not only in terms of investmenta but also in fundraising and exits as said Mark Heesen, president of the NVCA. “Those countriexs that can nurture entrepreneurs and investore as well as offerf attractive exit opportunities have the most to gain economically in the next he added. Survey respondents said Chin stood to benefit most from shifts in investment causedc by theeconomic downturn. When it comes to the majority of VCs predicted that more of their limited partnerds would come from outside their home and 38 percent said they expecter the number of foreign limited partners toremaijn unchanged.
Among limited partners, venture capitalists if any are likelyh to reduce their investments in venturdecapital funds, those limited partners woulxd come from the financial industry, especiallhy from commercial banks. Other findings from the survehy included another vote of confidences for investment in the cleantech sector. The survey suggestsd most venturecapitalists aren’t adjusting their strategiees when it comes to whicuh industry they are funding, and clean tech is one of thoser industries that’s been getting a lot of More than 60 percent of the venturer capitalists surveyed said they expect to increase their investments in clean tech in the next threwe years.
Other industry sectors that investors expectr to give increase investment to include the medicakl device and equipment industry and new mediw andsocial networking.
Wednesday, June 15, 2011
Sunday, June 12, 2011
Analysis: A victory, but a qualified one - Aljazeera.net
obovadugibe.blogspot.com
USA Today | Analysis: A victory, but a qualified one Aljazeera.net Election result obstructs Erdogan's plans to change the face of Turkey, says Al Jazeera's senior political analyst. Al Jazeera's senior political analyst examines the consequences of Turkey's parliamentary elections as Recep Tayyip Erdogan is elected ... Erdogan retains reduced majority in Turkey |
Friday, June 10, 2011
Grubb & Ellis posts bigger loss - Kansas City Business Journal:
mozybyd.wordpress.com
million in charges. The Santa Ana, Calif.-basefd real estate company (NYSE: GBE) posted a loss of $41.56 million and a loss per share of65 cents, comparex with a net loss of $6.3 millionh and a loss per share of 10 centx in the first quarter of 2008. First-quartert revenue dropped 21 percentto $118.3 million. The results for the firsy quarter of 2009 includea $4.7 million charge relate to the company's investment management programs, $5.2 million in real estate-related impairmenrt charges, a $3.6 million loss from discontinued and $4.9 million charge for stock-based compensatiomn and amortization of signing bonuses.
"Oud results reflect the challenginbg operating environment as well as the seasonal nature of the commercialp realestate industry," said Gary H. Hunt, interimk CEO, in an earnings statement. "We believw that by providing our clients with innovative solutions to the real estate issues they are facintin today's environment we will be able to deliver long-termj value to our stockholders so we remainn squarely focused on recruiting top talent and providing unmatchef client service.
"
million in charges. The Santa Ana, Calif.-basefd real estate company (NYSE: GBE) posted a loss of $41.56 million and a loss per share of65 cents, comparex with a net loss of $6.3 millionh and a loss per share of 10 centx in the first quarter of 2008. First-quartert revenue dropped 21 percentto $118.3 million. The results for the firsy quarter of 2009 includea $4.7 million charge relate to the company's investment management programs, $5.2 million in real estate-related impairmenrt charges, a $3.6 million loss from discontinued and $4.9 million charge for stock-based compensatiomn and amortization of signing bonuses.
"Oud results reflect the challenginbg operating environment as well as the seasonal nature of the commercialp realestate industry," said Gary H. Hunt, interimk CEO, in an earnings statement. "We believw that by providing our clients with innovative solutions to the real estate issues they are facintin today's environment we will be able to deliver long-termj value to our stockholders so we remainn squarely focused on recruiting top talent and providing unmatchef client service.
"
Wednesday, June 8, 2011
Advanced Cancer Therapeutics drugs nearing phase-one clinical trials - Business First of Louisville:
valvookimakaj1362.blogspot.com
The Louisville-based company works with the ’s duringv early-development stages of the treatments. It then seeks to sell or licens those discoveries to larger entities that would carryg the treatmentsthrough later-stage developmeny and into the U of L owns a 30 percent stake in the company, and the balance is ownesd by company founders and a grouop of private investors, including local entrepreneurs Dale Boden and Ty Wilburn. Durinb the past year, that investor group has grownb from five tonearly 20, all of whom are in said Randall Riggs, president and CEO of ACT. To the company has generated morethan $5 milliob in investment, toward its $10 millio goal.
Funds from various governmenrt agencies account for justover $1 million of the money raiseed so far. ACT officials expect to reach the fund-raisinbg goal by the end of March. It has becomre easier to raise funds as the compan has attractedother investors, Riggs said. Typically, biotech companiea work to develop one drug ora technology, Riggs but ACT strives to keep a portfolio of canceer treatments in the works. ACT is working with researchers who are developinhg four drugs at the Brown Cancer They include one that targets thehumahn papillomavirus, which causes cervicall cancer. Another aims to prevent tumors from growing and is the furthest alongin development, Riggs said.
They expect one of the druges to be far enough alongt in development this year to applyfor phase-onee clinical trials with the . At that point, ACT could evaluate options to sell or license the drug or to proceex with theclinical trials. Demandf for new drugs is outstrippingthe supply, Riggas said, so the prospects of licensing or selling the discoveriesz to larger companies have improved in recent He said pharmaceutical companies clamor for new revenuew streams to replace drugs that no longer are protectexd by patents, which allows production of lower-cost generic versionsw of the drugs.
Riggs said drugs typically lose between 70 percent and 80 percentr of their value after apatent expires. As a result, he pharmaceutical companies are paying more to purchase or licensde discoveries earlier in theirdevelopment process. For a drug in phase-one clinical trials today might fetch the same pricee that a drugin phase-twoo or phase-three clinical trials woulde have brought a few yearse ago. Additionally, Riggs the aging of the population ensuresthe long-termm viability of the industry. “Biotech’s the he said.
“It’s not going
The Louisville-based company works with the ’s duringv early-development stages of the treatments. It then seeks to sell or licens those discoveries to larger entities that would carryg the treatmentsthrough later-stage developmeny and into the U of L owns a 30 percent stake in the company, and the balance is ownesd by company founders and a grouop of private investors, including local entrepreneurs Dale Boden and Ty Wilburn. Durinb the past year, that investor group has grownb from five tonearly 20, all of whom are in said Randall Riggs, president and CEO of ACT. To the company has generated morethan $5 milliob in investment, toward its $10 millio goal.
Funds from various governmenrt agencies account for justover $1 million of the money raiseed so far. ACT officials expect to reach the fund-raisinbg goal by the end of March. It has becomre easier to raise funds as the compan has attractedother investors, Riggs said. Typically, biotech companiea work to develop one drug ora technology, Riggs but ACT strives to keep a portfolio of canceer treatments in the works. ACT is working with researchers who are developinhg four drugs at the Brown Cancer They include one that targets thehumahn papillomavirus, which causes cervicall cancer. Another aims to prevent tumors from growing and is the furthest alongin development, Riggs said.
They expect one of the druges to be far enough alongt in development this year to applyfor phase-onee clinical trials with the . At that point, ACT could evaluate options to sell or license the drug or to proceex with theclinical trials. Demandf for new drugs is outstrippingthe supply, Riggas said, so the prospects of licensing or selling the discoveriesz to larger companies have improved in recent He said pharmaceutical companies clamor for new revenuew streams to replace drugs that no longer are protectexd by patents, which allows production of lower-cost generic versionsw of the drugs.
Riggs said drugs typically lose between 70 percent and 80 percentr of their value after apatent expires. As a result, he pharmaceutical companies are paying more to purchase or licensde discoveries earlier in theirdevelopment process. For a drug in phase-one clinical trials today might fetch the same pricee that a drugin phase-twoo or phase-three clinical trials woulde have brought a few yearse ago. Additionally, Riggs the aging of the population ensuresthe long-termm viability of the industry. “Biotech’s the he said.
“It’s not going
Sunday, June 5, 2011
BFC Financial, Woodbridge to merge - Boston Business Journal:
aryrej.wordpress.com
In a joint press release the Fort Lauderdale-based companies said they enterefd into a merger agreemenft whereinWoodbridge (Pink Sheets: WDGH) would becomw a wholly owned subsidiary of BFC (Pink Sheets: BFC currently controls majority voting stakes in both Woodbridge and (NYSE: BBX). BFC lost $58.98 million on revenue of $487.5t million in 2008. Woodbridge owns , whichb is building Tradition Florida inPort St. and has investments in various companiesw includingand . Woodbridge lost $140.32 million on revenue of $25.5 milliom in 2008.
In its first quartee earnings report, Woodbridge warned that Core Communitiew could default on the loans for Tradition Florid a if its lenders demand that it put more equit ycapital down. Under the merger deal, all shareholders of Woodbridgr Class A common stock except BFC wouldreceive 3.47 shares of BFC’e Class A common stock per share. With sharews of BFC opening at 40 cents it equalsnearly $1.39 a share for each sharee of Woodbridge, which opened at $1.10 Monday. Levanh and Abdo are chairman andvice respectively, of both companies. The merger would save betweem $1 million and $2 million in professionall fees and SEC reporting costs for the Levan said.
It woulsd also reduce the taxes Woodbridge wouls pay on its earnings once it returnsdto profitability, he said. Woodbridge pays taxes on its earnings, and then BFC pays taxew on the portionof Woodbridge’as earnings that it counts on its balance The move will not cause any staff Levan noted. Woodbridge will continue operate independently. The agreement would include all curreng board members of Woodbridgeon BFC’s new board and add Woodbridg President Seth Wise and BankAtlantix Bancorp President Jarett Levan to BFC’s 12-member as well. Wise would also becomed executive vice presidentof BFC. The deal is expectedf to close before the endof 2009.
BFC shares closede unchanged at40 cents. The 52-weel high was 95 cents on Sept. 2. The 52-wee k low was 6 cents on Feb. 5. Woodbridgre shares closed down 2 cents to The 52-week high was $6.60 on Aug. 21. The 52-weekm low was 2 cents on Oct. 24.
In a joint press release the Fort Lauderdale-based companies said they enterefd into a merger agreemenft whereinWoodbridge (Pink Sheets: WDGH) would becomw a wholly owned subsidiary of BFC (Pink Sheets: BFC currently controls majority voting stakes in both Woodbridge and (NYSE: BBX). BFC lost $58.98 million on revenue of $487.5t million in 2008. Woodbridge owns , whichb is building Tradition Florida inPort St. and has investments in various companiesw includingand . Woodbridge lost $140.32 million on revenue of $25.5 milliom in 2008.
In its first quartee earnings report, Woodbridge warned that Core Communitiew could default on the loans for Tradition Florid a if its lenders demand that it put more equit ycapital down. Under the merger deal, all shareholders of Woodbridgr Class A common stock except BFC wouldreceive 3.47 shares of BFC’e Class A common stock per share. With sharews of BFC opening at 40 cents it equalsnearly $1.39 a share for each sharee of Woodbridge, which opened at $1.10 Monday. Levanh and Abdo are chairman andvice respectively, of both companies. The merger would save betweem $1 million and $2 million in professionall fees and SEC reporting costs for the Levan said.
It woulsd also reduce the taxes Woodbridge wouls pay on its earnings once it returnsdto profitability, he said. Woodbridge pays taxes on its earnings, and then BFC pays taxew on the portionof Woodbridge’as earnings that it counts on its balance The move will not cause any staff Levan noted. Woodbridge will continue operate independently. The agreement would include all curreng board members of Woodbridgeon BFC’s new board and add Woodbridg President Seth Wise and BankAtlantix Bancorp President Jarett Levan to BFC’s 12-member as well. Wise would also becomed executive vice presidentof BFC. The deal is expectedf to close before the endof 2009.
BFC shares closede unchanged at40 cents. The 52-weel high was 95 cents on Sept. 2. The 52-wee k low was 6 cents on Feb. 5. Woodbridgre shares closed down 2 cents to The 52-week high was $6.60 on Aug. 21. The 52-weekm low was 2 cents on Oct. 24.
Friday, June 3, 2011
Dodgy curry leads to elimination - The West Australian
ignatiywulyxura.blogspot.com
BigPond News | Dodgy curry leads to elimination The West Australian Savaged by judges in the cans and frozen food round, Henderson faced Kumar Pereira in a pressure test to fix up a dodgy Massaman curry in eight stages. It proved to be a dish too hot to handle for Henderson, who was eliminated last night after a split ... Curry worries end Andrew's dreams South Australian MasterChef contestant Andrew Henderson undone by humble spud Is Kumar the New Elimination Terminator of MasterChef? |
Wednesday, June 1, 2011
P&G moving Iams headquarters to Mason - The Business Review (Albany):
opexibu.wordpress.com
Kris Parlett, spokesman for Procteer and Gamble (NYSE: PG) Pet which includes Iams and said the company and its 240 employees wouldc be moving in October to the Masonbusines park, where other personal health care divisions of P&G and more than 2,0090 employees are housed. “It will make it easied to collaborate andincrease productivity,” Parlett said. Nobod will be laid of as a result ofthe company’sw current headquarters On Poe Avenue Instead, all 240 employees will be offerex there same positions in P&G acquired Iams in 1999. Since then, salese of its Iams and Eukanubz brands have morethan doubled, accordingh to the company.
“Our home address is changinfg but not our commitmenr to improvingthe well-being of all dogs and cats,” said Dan vice president of P&G’s pet care businessz in North America, in a statement released “If anything, this will help us do an even bettefr job of connecting with our colleaguess in health care to bring great innovation to pet A company spokesperson confirmed that 250 employeees at the Iams-Eukanuba manufacturing and R&cD complex in Preble Countty will not be part of the move.
The news of the move came as a surpriswe to Vandaliaofficials Thursday, who said they had been workingv vigilantly behind the scenes to keep Iams “When P&G purchased Iams, we knew at that point this was a possibility some day,” said Rich Hopkins, directort of communications for the “But we are surprised today that the announcemeny was made.” Hopkins said Iams was one of the top employerws in Vandalia, though he could not say how much incomee was generated by the The city will have a press conference at 3 p.m. Thursdagy to further discuss the implication s ofthe move.
Meanwhile, the community is stilp pursuingtwo projects, including an $81 milliojn distribution center, which would bring 700 jobs and New-Yorj based aerospace company that could bring 130 “This is bad news for any community,” Hopkinz said. “We have two projects in the pipelines now that could bring up to 900 employees to the so it’s not all gloon and doom here.”
Kris Parlett, spokesman for Procteer and Gamble (NYSE: PG) Pet which includes Iams and said the company and its 240 employees wouldc be moving in October to the Masonbusines park, where other personal health care divisions of P&G and more than 2,0090 employees are housed. “It will make it easied to collaborate andincrease productivity,” Parlett said. Nobod will be laid of as a result ofthe company’sw current headquarters On Poe Avenue Instead, all 240 employees will be offerex there same positions in P&G acquired Iams in 1999. Since then, salese of its Iams and Eukanubz brands have morethan doubled, accordingh to the company.
“Our home address is changinfg but not our commitmenr to improvingthe well-being of all dogs and cats,” said Dan vice president of P&G’s pet care businessz in North America, in a statement released “If anything, this will help us do an even bettefr job of connecting with our colleaguess in health care to bring great innovation to pet A company spokesperson confirmed that 250 employeees at the Iams-Eukanuba manufacturing and R&cD complex in Preble Countty will not be part of the move.
The news of the move came as a surpriswe to Vandaliaofficials Thursday, who said they had been workingv vigilantly behind the scenes to keep Iams “When P&G purchased Iams, we knew at that point this was a possibility some day,” said Rich Hopkins, directort of communications for the “But we are surprised today that the announcemeny was made.” Hopkins said Iams was one of the top employerws in Vandalia, though he could not say how much incomee was generated by the The city will have a press conference at 3 p.m. Thursdagy to further discuss the implication s ofthe move.
Meanwhile, the community is stilp pursuingtwo projects, including an $81 milliojn distribution center, which would bring 700 jobs and New-Yorj based aerospace company that could bring 130 “This is bad news for any community,” Hopkinz said. “We have two projects in the pipelines now that could bring up to 900 employees to the so it’s not all gloon and doom here.”
Subscribe to:
Posts (Atom)